Melanie De Almeida
Update: Belgian Stem Cell Therapy Closer to Market with Phase III Launch
German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases
Missed Labiotech Refresh? Have a Look at Our Recap!
Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust?
Norwegian Biotech Hits €21M in Private Placement for its Immunotherapies
German Biotech Unveils Positive Phase II Results for Alzheimer’s
This UK Biotech Wants to Protect People from Hearing Loss
French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug
This French Biotech Wants to Reinvent DC-based Immunotherapies
German Biotech Enters the Clinic with Next-Generation Antibody for AML
Swiss Researchers get to the Genetic Bottom of Kidney Cancer
FDA Fast Tracks Muscular Dystrophy Drug backed by Woodford
Labiotech UG, All Rights Reserved -
Send this to a friend